Therapeutics immunotargets for Tauopathy.

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a complex neurodegenerative condition characterized by intercellular pathological protein propagation, resembling prion-like mechanisms.
• This protein transfer is significantly amplified by interconnected pathological processes including neuroinflammation, mitochondrial dysfunction, oxidative stress, impaired autophagy, and cholinergic deficits.
• These factors collectively contribute to neuronal degeneration and cognitive decline in AD.

Purpose of the Study:

• To elucidate the multifactorial nature of Alzheimer's disease pathogenesis.
• To highlight the exacerbating roles of neuroinflammation, mitochondrial dysfunction, oxidative stress, autophagy impairment, and cholinergic deficits in disease progression.
• To identify potential therapeutic targets by examining the interplay of these mechanisms.

Main Methods:

• Review of existing literature on Alzheimer's disease pathology.
• Analysis of the molecular mechanisms underlying neuroinflammation, mitochondrial dysfunction, oxidative stress, autophagy, and cholinergic deficits in AD.
• Examination of the cross-talk between these pathological pathways.

Main Results:

• Chronic microglial activation drives neuroinflammation, increasing Tau hyperphosphorylation.
• Mitochondrial dysfunction leads to oxidative stress, damaging cellular components and accelerating neuronal injury.
• Impaired autophagy and mTOR signaling disrupt the clearance of amyloid-beta (Aβ) and Tau, promoting their aggregation.
• Cholinergic deficits contribute to memory and learning impairments.

Conclusions:

• Alzheimer's disease pathogenesis is driven by a complex interplay of neuroinflammation, mitochondrial dysfunction, oxidative stress, autophagy impairment, and cholinergic deficits.
• Therapeutic strategies targeting these interconnected pathways, including modulation of inflammation, restoration of mitochondrial and autophagy functions, and addressing Aβ and Tau, show promise for effective AD intervention.
• Developing interventions that address these multifactorial aspects is crucial for managing Alzheimer's disease.